Ads by Google
Epidemiological studies have suggested that dietary factors may be the cause for a higher risk of developing ovarian cancer. However, the risk of developing ovarian cancer can be reduced, through dietary changes, according to multiple studies.
The effectiveness of dietary changes on reducing risks and treating ovarian cancer has been confirmed by a recent animal based resear
Researchers at Kumamoto University in Japan say they have isolated a natural compound isolated from onions called onionin A (ONA) which has several properties that help fight ovarian cancer.
There has been a growing awareness of the value of good nutrition to help fight cancer. Recently a compound which is from onions has been found to have anti-cancer properties.
Diet and healthy weight are both factors that you can control to reduce your risk for ovarian cancer. A new study focuses on calcium and vitamin D intake, and their effect on your overall risk.
Ovarian cancer is the fifth leading cause of cancer death among women in the United States. Risk factors for the disease include:
A commonly used class of heart medications known as beta-blockers is shown in a first study to improve ovarian cancer survival. The medications block tumor growth and spread by interfering with the stress pathway involved with cancer metastasis.
Beta blockers have been shown in the past to slow cancer growth.
Concerns about potential health hazards from exposure to pesticides appear to have underestimated the serious nature of this problem.
Women who take fertility drugs should be aware of the health risks, but a new study indicates cancer is not one of them for most patients.
Development of a new test for ovarian cancer could dramatically increase the accuracy with which the disease is detected.
Women who take aspirin daily could lower their risk of ovarian cancer by up to 34 percent depending on dosage and frequency.
Doctors are limited in their ability to effectively screen for ovarian cancer, a type of cancer that is challenging to detect, especially in its early stages.
When a woman is recommended to undergo a hysterectomy, the question arises regarding whether to remove the ovaries at the time of surgery even if they are normal.
Most women with ovarian cancer fail to receive adequate care and miss out on treatments that could add a year or more to their lives, a new study shows.
Spirituality means something different to everyone, but in cancer care, being spiritual can have a
Results of new clinical trials have found intense treatment that involves bathing the abdomen with chemotherapy could offer potentially lifesaving treatment for women with ovarian cancer.
Women who carry the BRCA1 or BRCA2 gene mutations are at increased risk for ovarian cancer.
Ovary removal (oophorectomy) is often performed along with a hysterectomy in older women to avoid the risk of developing ovarian cancer.
In 2008, 21,204 women in the United States were diagnosed with ovarian cancer and 14,362 women in the United States died from ovarian cancer, according to the Centers for Disease Control and Preven
Five years ago, Diem Brown experienced both extreme joy and deep despair.
Ovarian cancer treated with Avastin (bevacizumab) was found to halt the progression of cancer for women with advanced stages of the disease, but questions remain whether the drug improves overall s
EUROPE—On December 23, the European Commission approved the use of bevacizumab (Avastin; Roche) for a new indication: newly-diagnosed ovarian cancer.
Researchers have discovered that ovarian cancer rapidly spreads to fat pads in the abdominal cavity.
A new study published in the British Journal of Cancer finds that women who have children or use hormonally-based birth control methods, such The Pill, have a reduced risk of ovarian cancer.
Ovarian cancer affects one in 70 women, and when it strikes, it is often deadly.
The results of the second Phase II study involving AstraZeneca’s olaparib have been released, and the news is promising that the drug is a new treatment option for patients with a more common form
Ovarian cancer is a formidable challenge to detect and treat, but now scientists have identified an antibody in the blood of infertile women that could eventually be used to screen for the disease
The risk of a woman developing ovarian cancer increases from 1 in 70 to 1 in 11 if she has a mutated DNA repair gene called RAD51D.
AstraZeneca has announced that their Phase II experimental drug, Olaparib, significantly extends progression-free survival for patients of a certain type of ovarian cancer.
Results of a large study have confirmed what previous research has shown: women who use talc powder have an increased risk of developing ovarian cancer.
